EP Patent

EP1904182A2 — Method for the treatment of drug abuse with flibanserin

Assigned to Boehringer Ingelheim International GmbH · Expires 2008-04-02 · 18y expired

What this patent protects

The invention relates to a method for the treatment of drug addiction, especially nicotine, ethanol and psychostimulants addiction, and for changing dependency-related behavior of a person suffering from substance addiction comprising the administration of a therpeutically effect…

USPTO Abstract

The invention relates to a method for the treatment of drug addiction, especially nicotine, ethanol and psychostimulants addiction, and for changing dependency-related behavior of a person suffering from substance addiction comprising the administration of a therpeutically effective amount of flibanserin.

Drugs covered by this patent

Patent Metadata

Patent number
EP1904182A2
Jurisdiction
EP
Classification
—
Expires
2008-04-02
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim International GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.